4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001437749-25-020045
Chief Medical Officer sold 5,162 shares at $7.37 ($38,044)
- Chief Medical Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schoenberg Mark · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-08 | Exercise or conversion : show line 1 in the form | +10,000 | 158,540 | D | ||
| 2025-06-09 | Sale : show line 2 in the form | −5,162 | $7.37 | $38,044 | 153,378 | D |
| Open-market sales · 5,162 sh · avg $7.37 · $38,044 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-08 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,000 | 10,000 | D |
Loading xslF345X05/rdgdoc.xml…